lobbying_activities: 2267173

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2267173	0bf954e1-7e54-4ecb-a45c-9403fca00c7d	Q1	AMERICAN PHARMACISTS ASSOCIATION	3071	AMERICAN PHARMACISTS ASSOCIATION	2019	first_quarter	CSP	S. 61 - Safe and Affordable Drugs from Canada Act of 2019 H.R. 447 - Affordable and Safe Prescription Drug Importation Act S. 97 - Affordable and Safe Prescription Drug Importation Act H.R. - BLOCKING Act of 2019; To amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval	HOUSE OF REPRESENTATIVES,SENATE		34000	0	0	2019-04-16T12:37:39.127000-04:00